![Christopher Boerner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Boerner
Vorstandsvorsitzender bei
BRISTOL-MYERS SQUIBB COMPANY
Vermögen: 10 Mio $ am 31.07.2026
Profil
Christopher S.
Boerner is Chairman & Chief Executive Officer at Bristol Myers Squibb Co. since 2024 and holds the same titles at The Bristol-Myers Squibb Canada Co. He is Director at Capital Health System, Inc. and Pharmaceutical Research & Manufacturers of America.
Starting in 2026, Dr. Boerner will be Independent Director at Colgate-Palmolive Co. Formerly, Dr. Boerner was Marketing Director at Genentech, Inc. in 2010, Independent Director at Achaogen, Inc. from 2014 to 2015, Vice President-Marketing at Dendreon Corp.
in 2010, Executive Vice President-Commercial at Seagen, Inc. from 2014 to 2015, and Associate at McKinsey & Co., Inc. Education includes undergraduate studies at Washington University in St. Louis and graduate and doctorate degrees from Haas School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.03.2026 | 146’890 ( 0.01% ) | 10 Mio $ | 31.07.2026 | |
| 11.05.2026 | 1’383 ( 0% ) | 126 268 $ | 31.07.2026 |
Aktuelle Nachrichten zu Christopher Boerner
Aktive Positionen von Christopher Boerner
| Unternehmen | Position | Beginn |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Vorstandsvorsitzender | 01.11.2023 |
| COLGATE-PALMOLIVE COMPANY | Direktor/Vorstandsmitglied | 15.03.2026 |
Capital Health System, Inc.
 Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Direktor/Vorstandsmitglied | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Christopher Boerner
| Unternehmen | Position | Ende |
|---|---|---|
| ACHAOGEN | Direktor/Vorstandsmitglied | 10.06.2015 |
| SEAGEN INC. | Corporate Officer/Principal | 30.01.2015 |
| DENDREON CORPORATION | Vertrieb & Marketing | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Vertrieb & Marketing | 01.01.2010 |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Christopher Boerner
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Colgate-Palmolive Co.
 Colgate-Palmolive Co. Household/Personal CareConsumer Non-Durables Manufactures and sells oral, personal, home care & pet nutritional products | Consumer Non-Durables |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Washington University in St. Louis
 Washington University in St. Louis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cancer medicines | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Capital Health System, Inc.
Capital Health System, Inc. Hospital/Nursing ManagementHealth Services Owns and operates hospitals | Health Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bristol-Myers Squibb Canada Co.
Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Specializes in the research, development and manufacturing of oncology, immunology, hematology and cardiovascular diseases | Health Technology |
